Guggenheim Maintains Buy on Illumina, Raises Price Target to $180

Benzinga Newsdesk www.benzinga.com Positive 83.2%

Neg 0% Neu 0% Pos 83.2%

Guggenheim analyst Subbu Nambi maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price target from $170 to $180.